China CAS:57-83-0 Manufacturer

We are commitment to offer the competitive price ,outstanding products quality, as well as fast delivery for CAS:57-83-0, With our rules of " small business track record, partner trust and mutual benefit", welcome all of you to definitely work together , expand with each other.
CAS:57-83-0, Our aim is to help customers realize their goals. We have been making great efforts to achieve this win-win situation and sincerely welcome you to join us. In a word, when you choose us, you choose a perfect life. Welcome to visit our factory and welcome your order! For further inquiries, remember to do not hesitate to contact us.

Hot Products

  • Abiraterone Acetate

    Abiraterone Acetate

    Abiraterone Acetate has CP,USP specifications. DMF, WC available.

    CAS:154229-18-2

  • Dienogest

    Dienogest

    Dienogest has EP specifications. DMF approved.

    CAS:65928-58-7

  • Fluticasone Propionate

    Fluticasone Propionate

    Fluticasone propionate has CP, EP and USP specifications. DMF available.

    CAS:80474-14-2

  • DHEA Acetate(Prasterone Acetate)

    DHEA Acetate(Prasterone Acetate)

    DHEA Acetate(Prasterone Acetate) is the intermediate of DHEA(prasterone).

    CAS:853-23-6

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • 4-aza-5α-androstan-3-oxo-17β-carboxylic acid

    4-aza-5α-androstan-3-oxo-17β-carboxylic acid

    4-aza-5α-androstan-3-oxo-17β-carboxylic acid is an intermediate of Dutasteride.

    CAS:104239-97-6

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept